Nemaura Financial Statements From 2010 to 2025
Nemaura Medical financial statements provide useful quarterly and yearly information to potential Nemaura Medical investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Nemaura Medical financial statements helps investors assess Nemaura Medical's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Nemaura Medical's valuation are summarized below:Nemaura Medical does not presently have any fundamental ratios for analysis.
This module can also supplement various Nemaura Medical Technical models . Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
Check Nemaura Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nemaura Medical's main balance sheet or income statement drivers, such as , as well as many indicators such as . Nemaura financial statements analysis is a perfect complement when working with Nemaura Medical Valuation or Volatility modules.
Nemaura |
Nemaura Medical Company Return On Equity Analysis
Nemaura Medical's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Nemaura Medical Return On Equity | -7.24 |
Most of Nemaura Medical's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nemaura Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, Nemaura Medical has a Return On Equity of -7.2444. This is 69.78% lower than that of the Health Care Equipment & Supplies sector and 17.02% lower than that of the Health Care industry. The return on equity for all United States stocks is notably higher than that of the company.
Nemaura Medical Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Nemaura Medical's current stock value. Our valuation model uses many indicators to compare Nemaura Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Nemaura Medical competition to find correlations between indicators driving Nemaura Medical's intrinsic value. More Info.Nemaura Medical is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Nemaura Medical's earnings, one of the primary drivers of an investment's value.Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Consideration for investing in Nemaura Pink Sheet
If you are still planning to invest in Nemaura Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Nemaura Medical's history and understand the potential risks before investing.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |